CD8A and neoplasm: Conversely, Zhou et al. [119] carried out in 73 stage IV CRC patients the different expressions of lymphocyte subpopulations in the primary tumor and secondary cancer sites (peritoneal and liver lesions) and observed a higher expression of CD8+ and lower expression of CD4+ in the secondary site than the primary tumor.